The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease

Glucose uptake in the brain decreases because of normal aging but this decline is accelerated in Alzheimer’s disease (AD) patients. In fact, positron emission tomography (PET) studies have shown that metabolic reductions in AD patients occur decades before the onset of symptoms, suggesting that meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukke, Vidyasagar Naik, Villani, Rosanna, Archana, Moola, Wawrzyniak, Agata, Balawender, Krzysztof, Orkisz, Stanislaw, Ferraro, Luca, Serviddio, Gaetano, Cassano, Tommaso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589651/
https://www.ncbi.nlm.nih.gov/pubmed/33086751
http://dx.doi.org/10.3390/ijms21207739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589651/
https://www.ncbi.nlm.nih.gov/pubmed/33086751
http://dx.doi.org/10.3390/ijms21207739

Ejemplares similares